XML 54 R42.htm IDEA: XBRL DOCUMENT v3.25.1
Description of the Business (Details)
$ / shares in Units, $ in Thousands
3 Months Ended
Jul. 02, 2024
USD ($)
$ / shares
shares
Apr. 04, 2024
Mar. 27, 2024
Dec. 06, 2023
Nov. 13, 2023
USD ($)
$ / shares
shares
Mar. 31, 2025
USD ($)
$ / shares
Dec. 31, 2024
USD ($)
$ / shares
Cash and Cash Equivalents [Line Items]              
Common stock, par value (in dollars per share) | $ / shares         $ 0.0001 $ 0.0001 $ 0.0001
Temporary equity, par value (in dollars per share) | $ / shares         $ 0.0001    
Reverse stock split conversion ratio   0.0333          
Cash, cash equivalents, restricted cash and marketable securities | $           $ 182,100  
Restricted cash and cash equivalents | $           1,700  
Accumulated deficit | $           $ 709,781 $ 692,071
Minimum              
Cash and Cash Equivalents [Line Items]              
Reverse stock split conversion ratio     0.05        
Maximum              
Cash and Cash Equivalents [Line Items]              
Reverse stock split conversion ratio     0.0333        
Securities Purchase Agreement              
Cash and Cash Equivalents [Line Items]              
Sale of stock, number of shares issued in transaction (in shares) | shares         149,330.115    
Total aggregate purchase price | $         $ 60,250    
July 2024 Purchase Agreement              
Cash and Cash Equivalents [Line Items]              
Sale of stock, price per share (in dollars per share) | $ / shares $ 20.00            
Sale of stock, gross consideration received on transaction | $ $ 130,000            
Common stock | July 2024 Purchase Agreement              
Cash and Cash Equivalents [Line Items]              
Sale of stock, number of shares issued in transaction (in shares) | shares 3,563,247            
Series B Preferred Stock              
Cash and Cash Equivalents [Line Items]              
Common stock, par value (in dollars per share) | $ / shares $ 0.0001            
Series B Preferred Stock | July 2024 Purchase Agreement              
Cash and Cash Equivalents [Line Items]              
Sale of stock, number of shares issued in transaction (in shares) | shares 2,937,903            
Old Cartesian              
Cash and Cash Equivalents [Line Items]              
Contingent value right, percentage of milestone payments, royalties and other amounts to be distributed       100.00%   100.00%  
Old Cartesian | Common stock              
Cash and Cash Equivalents [Line Items]              
Issuance of shares (in shares) | shares         224,099    
Old Cartesian | Preferred stock | Series A Preferred Stock              
Cash and Cash Equivalents [Line Items]              
Issuance of shares (in shares) | shares         384,930.724